Form 4: Moderna CEO Sells Shares
Insider Transaction (Form 4)
Stephane Bancel, Chief Executive Officer and a Director of Moderna, Inc., sold 499,246 shares of common stock on August 5, 2026.
Summary
- Option exercise/conversion: acquired 499,246 Common Stock at $19.15 ($9,560,561) on August 5, 2026; holds 6,687,037 after (Direct).
- Open-market sale: disposed of 147,473 Common Stock at $56.21 ($8,289,457) on August 5, 2026; holds 6,539,564 after (Direct).
- Open-market sale: disposed of 124,838 Common Stock at $56.96 ($7,110,772) on August 5, 2026; holds 6,414,726 after (Direct).
- Open-market sale: disposed of 39,891 Common Stock at $58.12 ($2,318,465) on August 5, 2026; holds 6,374,835 after (Direct).
- Open-market sale: disposed of 187,044 Common Stock at $58.79 ($10,996,317) on August 5, 2026; holds 6,187,791 after (Direct).
- Option exercise/conversion: acquired 252,469 Common Stock at $19.15 ($4,834,781) on August 6, 2026; holds 6,440,260 after (Direct).
- Option exercise/conversion: disposed of 370,853 Stock Option (Right to Buy) on August 5, 2026; holds 187,541 after (Direct).
- Option exercise/conversion: disposed of 128,393 Stock Option (Right to Buy) on August 5, 2026; holds 64,928 after (Direct).
- Option exercise/conversion: disposed of 187,541 Stock Option (Right to Buy) on August 6, 2026 (Direct).
- Option exercise/conversion: disposed of 64,928 Stock Option (Right to Buy) on August 6, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $28,715,011 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Stephane Bancel — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Option exercise/conversion | Common Stock | 499,246 | $19 | $9.6M | 6,687,037 |
| 2026-08-05 | Open-market sale | Common Stock | 147,473 | $56 | $8.3M | 6,539,564 |
| 2026-08-05 | Open-market sale | Common Stock | 124,838 | $57 | $7.1M | 6,414,726 |
| 2026-08-05 | Open-market sale | Common Stock | 39,891 | $58 | $2.3M | 6,374,835 |
| 2026-08-05 | Open-market sale | Common Stock | 187,044 | $59 | $11.0M | 6,187,791 |
| 2026-08-06 | Option exercise/conversion | Common Stock | 252,469 | $19 | $4.8M | 6,440,260 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 370,853 | — | — | 187,541 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 128,393 | — | — | 64,928 |
| 2026-08-06 | Option exercise/conversion | Stock Option (Right to Buy) | 187,541 | — | — | 0 |
| 2026-08-06 | Option exercise/conversion | Stock Option (Right to Buy) | 64,928 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Option exercise/conversion (499,246 shares) |
| 2026-08-05 | Open-market sale (147,473 shares) |
| 2026-08-05 | Open-market sale (124,838 shares) |
| 2026-08-05 | Open-market sale (39,891 shares) |
| 2026-08-05 | Open-market sale (187,044 shares) |
| 2026-08-06 | Option exercise/conversion (252,469 shares) |
| 2026-08-05 | Option exercise/conversion (370,853 shares) |
| 2026-08-05 | Option exercise/conversion (128,393 shares) |
| 2026-08-06 | Option exercise/conversion (187,541 shares) |
| 2026-08-06 | Option exercise/conversion (64,928 shares) |
Keywords
insider transaction, Form 4, MRNA, Moderna, Inc., bearish, Stephane Bancel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.